GSE155031 catechin SH-SY5Y 6 v 0 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE155031_catechin_SH-SY5Y_6_v_0_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE155031_catechin_SH-SY5Y_6_v_0_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE155031_catechin_SH-SY5Y_6_v_0_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE155031_catechin_SH-SY5Y_6_v_0_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

family with sequence similarity 30 member A

Gene

POU class 3 homeobox 3

Gene

long intergenic non-protein coding RNA 641

Gene

KDM7A divergent transcript

Gene

ID2 antisense RNA 1

Gene

sphingomyelin phosphodiesterase 4B, pseudogene

Gene

uncharacterized protein MGC12916

Gene

ribosomal protein L23a pseudogene 82

Gene

MIR600 host gene

Gene

MT-ND1 pseudogene 23

  • Gene

    family with sequence similarity 30 member A


  • Gene

    POU class 3 homeobox 3


  • Gene

    long intergenic non-protein coding RNA 641


  • Gene

    KDM7A divergent transcript


  • Gene

    ID2 antisense RNA 1


  • Gene

    sphingomyelin phosphodiesterase 4B, pseudogene


  • Gene

    uncharacterized protein MGC12916


  • Gene

    ribosomal protein L23a pseudogene 82



  • Gene

    MT-ND1 pseudogene 23

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.